BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15966900)

  • 1. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway.
    Minegishi N; Suzuki N; Kawatani Y; Shimizu R; Yamamoto M
    Genes Cells; 2005 Jul; 10(7):693-704. PubMed ID: 15966900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
    Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
    Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential GATA factor stabilities: implications for chromatin occupancy by structurally similar transcription factors.
    Lurie LJ; Boyer ME; Grass JA; Bresnick EH
    Biochemistry; 2008 Jan; 47(3):859-69. PubMed ID: 18154321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
    Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-associated protein-43 is degraded via the ubiquitin-proteasome system.
    De Moliner KL; Wolfson ML; Perrone Bizzozero N; Adamo AM
    J Neurosci Res; 2005 Mar; 79(5):652-60. PubMed ID: 15668958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway.
    Xia H; Redman C
    Biochem Biophys Res Commun; 1999 Aug; 261(3):590-7. PubMed ID: 10441471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
    Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
    Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitors MG132 and lactacystin hyperphosphorylate HSF1 and induce hsp70 and hsp27 expression.
    Kim D; Kim SH; Li GC
    Biochem Biophys Res Commun; 1999 Jan; 254(1):264-8. PubMed ID: 9920768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Artifitial increase of HIV-1 reverse transcriptase turnover through proteasome pathway].
    Starodubova ES; Isaguliants MG; Karpov VL
    Mol Biol (Mosk); 2006; 40(6):982-8. PubMed ID: 17209425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome-dependent degradation of the human estrogen receptor.
    Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEST motif sequence regulating human NANOG for proteasomal degradation.
    Ramakrishna S; Suresh B; Lim KH; Cha BH; Lee SH; Kim KS; Baek KH
    Stem Cells Dev; 2011 Sep; 20(9):1511-9. PubMed ID: 21299413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitylation and destruction of endogenous c-mycS by the proteasome: are myc boxes dispensable?
    Chen L; Smith L; Accavitti-Loper MA; Omura S; Bingham Smith J
    Arch Biochem Biophys; 2000 Feb; 374(2):306-12. PubMed ID: 10666312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression.
    Das A; Boggaram V
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L74-84. PubMed ID: 16905641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron-dependent degradation of apo-IRP1 by the ubiquitin-proteasome pathway.
    Wang J; Fillebeen C; Chen G; Biederbick A; Lill R; Pantopoulos K
    Mol Cell Biol; 2007 Apr; 27(7):2423-30. PubMed ID: 17242182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early degradation of paternal mitochondria in domestic pig (Sus scrofa) is prevented by selective proteasomal inhibitors lactacystin and MG132.
    Sutovsky P; McCauley TC; Sutovsky M; Day BN
    Biol Reprod; 2003 May; 68(5):1793-800. PubMed ID: 12606393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway.
    Mezey E; Rennie-Tankersley L; Potter JJ
    Biochem Biophys Res Commun; 2001 Jul; 285(3):644-8. PubMed ID: 11453641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell senescence inducing gene product MORF4 is regulated by degradation via the ubiquitin/proteasome pathway.
    Tominaga K; Tominaga E; Ausserlechner MJ; Pereira-Smith OM
    Exp Cell Res; 2010 Jan; 316(1):92-102. PubMed ID: 19769966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional repression of E2F gene by proteasome inhibitors in human osteosarcoma cells.
    Lim JH; Chang YC; Park YB; Park JW; Kwon TK
    Biochem Biophys Res Commun; 2004 Jun; 318(4):868-72. PubMed ID: 15147952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.